A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Phase of Trial: Phase II/III
Latest Information Update: 22 Mar 2018
At a glance
- Drugs Edivoxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 27 Sep 2016 Results of pooled analysis from 4 adjunctive treatment trials and 1 monotherapy trial (n=2561) published in the Journal of Clinical Psychiatry.
- 13 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Mar 2010 Actual patient number (495) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History